Rampart IC, a developer of radiation shielding for interventional suites, announced new data on the reduction in radiation ...
Angiolutions announced that the first patient has been treated in a first-in-human (FIH) study evaluating the safety and ...
Bentley InnoMed GmbH, which is headquartered in Hechingen, Germany, announced the first-in-human use of the company’s BeG ...
Solaris Endovascular announced 12-month results from the Solaris SX iliac postmarket clinical follow-up study of the company&rs ...
Penumbra Inc. announced it has secured CE Mark approval for its Lightning Bolt 12 and Lightning Bolt 6X with Trax. These next-g ...
Healionics Corporation, a developer of synthetic biomaterial-based medical devices, announced recently that 24-month clinical ...
Akura Medical, a Shifamed portfolio company focused on venous thromboembolism care, announced it has secured a $53 million firs ...
Royal Philips announced the expanded commercial availability of its LumiGuide device guidance across Europe and the United Stat ...
Okami Medical, Inc., a developer of vascular embolization solutions, announced that Drew Hykes was appointed President and ...
Pathfinder Medical, a United Kingdom-based developer of minimally invasive vascular access technologies, announced the appoint ...
With the Sublime™ Microcatheter, I’ve found excellent balance between push, flexibility, and torqueability. I find it handles ...
AD, its design and what makes it unique, how funding was obtained, the role of the patient advocacy group, and more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results